Emergent is hiring several positions at their Canton, MA site to support a growing portfolio of programs. In June 2020, Emergent announced a $75M investment into its Canton, Massachusetts drug substance facility, increasing its campus footprint and expanding its manufacturing capabilities into viral vector-based gene therapy.
The ongoing pandemic response by the biopharma industry has been historic. Biotech companies and contract development and manufacturing organizations, along with the entire supply chain, have worked together to develop several SARS-CoV-2 vaccines, achieved Emergency Use Authorization(EUA) from the FDA, and began delivering desperately needed protection into people’s arms in less than a calendar year.
While the pandemic has forced many industries to downsize, biotech companies have had the opportunity — or sometimes the obligation — to ramp up. Just take a look at Catalent Pharma Solutions, the Baltimore-based contract manufacturer. The company has hired over 500 new employees since last March, said Talent Acquisition Specialist Charle’ Lamb during a panel at the Biohealth Industry Day.
2020 was a year like no other for BioHealth Capital Region (BCHR) biotechs, and this year is expected to bring substantial growth across many sectors.
All-in-one Sensing System Poised to Unlock Bioprocessing “Black Box” PITTSBURGH, PA / ACCESSWIRE / February 16, 2021 / Scientific Bioprocessing, Inc. (SBI), a subsidiary of publicly-owned Scientific Industries, Inc. (OTCQB:SCND), announced today the launch of its Intelligent, Dynamic (ID) Fiber Optic Kit. The ID·Fiber Optic Kit is an all-in-one pH and dissolved oxygen sensing solution…
EVerZom, a biopharmaceutical company specialized in the bioproduction of exosomes, announced today that it has raised €1.1 million in funding from institutional and private investors to develop its exosome bioproduction platform.
LEARN ABOUT CAREERS AT EMERGENT BIOSOLUTIONS Be part of a bold mission – To protect and enhance life! Emergent is hiring for dozens of full-time manufacturing leadership roles to support [….]
Maryland Biomanufacturing Leaders Discuss Challenges, Future Needs at 2020 Bio Innovation Conference
The BioHealth Capital Region (BHCR) is known globally as a leading vaccine hub with nearly 20% of the world’s leading vaccine development influencers in Maryland, which is the heart of the BHCR.
New Alliance Launches to Make it Easier for Biopharma Companies to Reshore Manufacturing Operations in US
RMI Peoples Choice for Maryland Champions of Manufacturing – BioManufacturing BioBuzz